Biogen Inc (NASDAQ:BIIB) stock end the session low on Friday.
BIIB stock fell over 1.15% to close at $283.19. More than 940K shares traded hands for the session, compared to its 30-day average volume of 1.08 million shares. The stock opened at $288.24 and moved within a range of $282.78 – 289.91 on Friday.
BIIB Issued News
Biogen and Ginkgo Bioworks Announce Collaboration and License Agreement to Develop Novel Gene Therapy Manufacturing Platform
- BIIB announced a gene therapy collaboration. Together, the companies aim to redefine the industry standard for manufacturing recombinant adeno-associated virus (AAV)-based vectors.
- Recombinant AAV-based vectors are widely used to develop innovative gene therapies and have the potential to treat certain neurological and neuromuscular diseases as well as other conditions across multiple therapeutic areas.
|SHARES OUTSTANDING||150.55 M|
|SHARE FLOAT (%)||150.27 M (99.81%)|
|% HELD BY INSTITUTIONS||86.70|
Recent Stock Performance
|+/- EMA(20)||276.94 (+2.26%)|
|+/- SMA(50)||271.42 (+4.34%)|
|+/- SMA(200)||268.80 (+5.35%)|
|CCI20||131.5321||Buy||Chaikin Money Flow||0.0605||Buy|
|MACD||3.7065||Buy||Money Flow Index||45.8641||Sell|